January 21, 2025CorporateTerumo Blood and Cell Technologies and Akron Bio Complete Collaborative Study on MSC Expansion Using Quantum FlexStudy confirms that Terumo BCT’s Quantum Flex platform, paired with Akron Bio’s GMP virus-inactivated fibronectin reagent, provides a scalable and compliant solution for MSC expansion
January 20, 2025CorporateTerumo Blood and Cell Technologies Highlights the Future of Blood in DAVOS Interviews 2025 Film SeriesCEO Antoinette Gawin discusses unlocking the potential of blood and cells to transform healthcare on CBSnews.com
January 20, 2025CorporateTerumo Blood and Cell Technologies Reaches Strategic Partnership With Shandong Institute of Medical Devices and Pharmaceutical Packaging Inspection to Facilitate High-Quality Development of China’s Medical Device Industry
Top
Top